Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.2 USD | +0.56% | -0.96% | +7.46% |
May. 20 | Barclays Adjusts Price Target on GoodRx to $10 From $9, Maintains Overweight Rating | MT |
May. 17 | UBS Adjusts Price Target on GoodRx Holdings to $9 From $8, Maintains Neutral Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.46% | 2.7B | |
+30.04% | 457B | |
+31.55% | 276B | |
+6.35% | 137B | |
+29.35% | 93.68B | |
+4.83% | 90.6B | |
+58.99% | 59.25B | |
+12.88% | 45.65B | |
+24.63% | 37.59B | |
-0.23% | 35.62B |
- Stock Market
- Equities
- GDRX Stock
- News GoodRx Holdings, Inc.
- RBC Raises Price Target on GoodRx Holdings to $8 From $7, Keeps Sector Perform Rating